The main update at the August town hall was a preview of impending antigen test policy changes.
- Antigen tests and sensitivity; Early in the pandemic, the FDA established that the relative lower sensitivity associated with at-home antigen tests could be offset through a serial testing strategy. In effect, the agency has allowed over-the-counter (OTC) antigen tests for Covid-19 to be authorized even with a lower sensitivity per administration of the test, so long as the cumulative sensitivity of multiple tests undertaken in a set amount of time would meet the agency’s performance baseline.
Fill out the form to read the full article.
